PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer

Published:2018-03-15 Issue:6 Volume:7 Page:e1433981
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Dosset Magalie¹²³⁴,Vargas Thaiz Rivera¹⁴,Lagrange Anaïs¹⁴,Boidot Romain¹⁴⁵,Végran Frédérique¹⁴⁵,Roussey Aurélie¹⁴,Chalmin Fanny¹⁴,Dondaine Lucile¹⁴,Paul Catherine¹⁴,Marie-Joseph Elodie Lauret²⁴,Martin François¹⁴,Ryffel Bernhard⁶,Borg Christophe²⁴⁷,Adotévi Olivier²⁴⁷,Ghiringhelli François¹⁴⁵,Apetoh Lionel¹⁴⁵

Affiliation:

1. INSERM, U1231, Dijon, France

2. INSERM, U1098, Besançon, France

3. LabEx LipSTIC, Besançon, France

4. Université de Bourgogne Franche Comté, Dijon, France

5. Centre Georges François Leclerc, Dijon, France

6. University of Cape Town, RSA, CNRS, UMR7355, Orleans, France, IDM

7. Department of Medical Oncology, University Hospital of Besançon, France

Funder

French National Research Agency

ERC

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1433981

Reference35 articles.

1. Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

2. FOLFOX Alternated with FOLFIRI as First-Line Chemotherapy for Metastatic Colorectal Cancer

3. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

4. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

5. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies;International Journal of Molecular Sciences;2024-08-30

2. Effects of PD-L1 Inhibitors on Mitochondrial Function in Melanoma A375 Cells: Unveiling a Shielded Drug Resistance Mechanism;2024-08-09

3. Efficacy of novel allogeneic cancer cells vaccine to treat colorectal cancer;Frontiers in Oncology;2024-07-24

4. Injectable Hydrogels for Intratumoral Administration Against Breast Cancer;Journal of Polymers and the Environment;2024-07-09

5. Chemoimmunotherapy combinations: translating basic knowledge into clinical successes;Genes & Immunity;2024-03-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3